What You Should Know:
– Power, the company transforming the traditional clinical trial landscape, announced today the close of their $11.9M Series A funding round led by Kin, Contrary, and Footwork.
– The strategic funding fuels Power’s mission to democratize access to clinical trials and diversify the pool of participants, ultimately accelerating life-saving medical research.
Revolutionizing Clinical Trial Participation
Founded in 2021 by Brandon Li and Michael Gill, Power recognized the complex and opaque nature of clinical trial recruitment. By offering a patient-centric platform, they have empowered hundreds of thousands of individuals to:
– Discover relevant trials: Easily search for studies based on specific needs and criteria.
– Understand the process: Access plain-language summaries and connect directly with researchers.
– Participate with confidence: Feel supported throughout the journey, from enrollment to completion.
Impactful Growth
To date, over 600,000 patients used Power to find clinical trials in the past year. Study team participation on the platform is growing by 20% monthly, leading to increased efficiency and faster enrollment. Power is actively fostering diversity, with studies attracting participants who better reflect the US population.
Expansion Plans
The latest funding empowers Power to expand its platform, support researchers and create a more equitable clinical trial ecosystem.
